Skip to content

Splenic Diffuse Red Pulp Small B Cell Lymphoma C2699508

Published: July 22, 2026Updated: August 27, 2026

A rare blood cancer originating in the spleen involving abnormal B cells. Typically affects middle-aged to older adults. Treatment may include spleen removal and immunotherapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
moderate
Chronic
true

Medication Comparisons

Compare medications used to treat Splenic Diffuse Red Pulp Small B Cell Lymphoma C2699508. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy